Login / Signup

Evaluation of Postmarketing Reports from Industry-Sponsored Programs in Drug Safety Surveillance.

Lisa WolfDipti KalraCindy M KortepeterMonica A MuñozEileen WuGerald J Dal Pan
Published in: Drug safety (2020)
Our study suggests that reports obtained from industry-sponsored programs in the Food and Drug Administration Adverse Event Reporting System database contain more data elements but are similar to non-industry-sponsored program reports with regard to 'usefulness' in signal detection.
Keyphrases
  • adverse drug
  • drug administration
  • electronic health record
  • public health
  • emergency department
  • drug induced
  • quality improvement
  • big data
  • risk assessment
  • human health
  • artificial intelligence
  • data analysis